Endogenous guanidino compounds as uremic neurotoxins
- 1 February 2001
- journal article
- review article
- Published by Elsevier in Kidney International
- Vol. 59, S77-S83
- https://doi.org/10.1046/j.1523-1755.2001.59780077.x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Uraemic guanidino compounds inhibit γ-aminobutyric acid-evoked whole cell currents in mouse spinal cord neuronesNeuroscience Letters, 1999
- N-methyl-d-aspartate receptor activation by guanidinosuccinate but not by methylguanidine: Behavioural and electrophysiological evidenceNeuropharmacology, 1996
- Guanidino compound levels in brain regions of non-dialyzed uremic patientsNeurochemistry International, 1995
- The uremic quanidino compound guanidinosuccinic acid induces behavioral convulsions and concomitant epileptiform electrocorticographic discharges in miceBrain Research, 1992
- Guanidinosuccinic acid inhibits excitatory synaptic transmission in CA1 region of rat hippocampal slicesAnnals of Neurology, 1991
- Guanidino compounds that are increased in cerebrospinal fluid and brain of uremic patients inhibit GABA and glycine responses on mouse neurons in cell cultureAnnals of Neurology, 1990
- The epileptogenic action of the taurine analogue guanidinoethane sulfonate may be caused by a blockade of GABA receptorsJournal of Neuroscience Research, 1990
- Serum Guanidino Compound Levels and the Influence of a Single Hemodialysis in Uremic Patients Undergoing Maintenance HemodialysisNephron, 1987
- Guanidino compounds in uraemic dialysed patientsClinica Chimica Acta; International Journal of Clinical Chemistry, 1986
- γ-Guanidinobutyric Acid as a Convulsive SubstanceNature, 1966